Dilantin-125

Parke-Davis Div of Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Mar 11, 2022
Approval ID: 051742b5-b0f0-44a5-8d31-3288527b0638
Products: 1 registered
Version: 47

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DILANTIN-125 safely and effectively. See full prescribing information for DILANTIN-125. DILANTIN-125 (phenytoin) oral suspension Initial U.S. Approval: 1953

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.